1,476 results on '"Hendlisz A"'
Search Results
2. Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making
3. State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies
4. Non-operative management after immune checkpoint inhibitors for early-stage, dMMR/MSI-H gastrointestinal cancers
5. The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study
6. Neoadjuvant chemotherapy for early-stage colon cancer
7. PD-L1 Expression in Paired Samples of Rectal Cancer
8. Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study
9. Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers
10. Tumor biology reflected by histological growth pattern is more important than surgical margin for the prognosis of patients undergoing resection of colorectal liver metastases
11. Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer
12. ASO Visual Abstract: The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases—A Pilot Study
13. Immunotherapies in non-metastatic gastrointestinal cancers
14. Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?
15. Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy
16. 177Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors.
17. Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial
18. Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study
19. Targeted agents in older patients with gastrointestinal cancers – An overview
20. The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective analysis
21. Fortnightly or fractionated weekly docetaxel–cisplatin–5‐FU as first‐line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study
22. Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study
23. MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer
24. PD-L1 Expression in Paired Samples of Rectal Cancer.
25. Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients
26. Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis
27. Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials
28. Mind the target: human epidermal growth factor receptor 2 in colorectal cancer
29. Editorial: ’All you need is immunotherapy’: a new treatment paradigm in sight for early-stage, mismatch repair-deficient/microsatellite instability high gastrointestinal cancers?
30. First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): 64-month (mo) follow-up from CheckMate 142.
31. Prediction of177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
32. Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer
33. The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases
34. Personalized selective internal radiation therapy in liver metastasis of thyroid cancer with impaired liver function: A case report
35. Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy
36. Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance
37. Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma
38. CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial
39. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials
40. Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review
41. The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study
42. Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study
43. Adjuvant chemotherapy for gastrointestinal cancers: we can do much better
44. Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer
45. Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies
46. Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study
47. Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients
48. Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis
49. Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?
50. 90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.